"The US Food and Drug Administration (FDA) has approved the tumor necrosis factor inhibitor adalimumab (Humira, AbbVie) for the treatment of moderate to severe hidradenitis suppurativa (HS), making it the first and only FDA-approved therapy"...
Acticin Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Acticin (permethrin) Cream 5% is a topical (for the skin) scabicidal agent used to treat scabies. Acticin Cream is available in generic form. Common side effects of Acticin Cream include skin irritation including mild burning and stinging immediately following application of cream, itching, skin swelling or redness, numbness, tingling, and rash.
One application of Acticin Cream is generally curative, and usually a 30 gram dose is sufficient for an average adult. Thoroughly massage Acticin Cream into the skin from the head to the soles of the feet. Remove the cream by washing (shower or bath) after 6 to 14 hours. Infants should be treated on the scalp, temple and forehead. Acticin may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Acticin Cream should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Acticin (permethrin) Cream 5% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Acticin FDA Prescribing Information: Side Effects
In clinical trials, generally mild and transient burning and stinging followed application with permethrin cream in 10% of patients and was associated with the severity of infestation. Pruritis was reported in 7% of patients at various times post- application. Erythema, numbness, tingling, and rash were reported in 1 to 2% or less of patients (see PRECAUTIONS: General).
Read the entire FDA prescribing information for Acticin (Permethrin)
Additional Acticin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.